Logo image of NXP

NUVEEN SELECT TAX-FREE INC (NXP) Stock Overview

USA - NYSE:NXP - US67062F1003

14.45 USD
-0.14 (-0.96%)
Last: 9/26/2025, 8:17:42 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NXP. NXP was compared to 0 industry peers in the Unkown industry. The financial health of NXP is average, but there are quite some concerns on its profitability. NXP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NXP had positive earnings in the past year.
In multiple years NXP reported negative net income over the last 5 years.
NXP had a negative operating cash flow in each of the past 5 years.
NXP Yearly Net Income VS EBIT VS OCF VS FCFNXP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M

1.2 Ratios

Industry RankSector Rank
ROA 10.22%
ROE 10.33%
ROIC 3.27%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NXP Yearly ROA, ROE, ROICNXP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 -4 6 -6

1.3 Margins

NXP's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of NXP has remained more or less at the same level.
NXP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 96.77%
PM (TTM) 241.94%
GM 95.35%
OM growth 3Y0.23%
OM growth 5Y0.16%
PM growth 3YN/A
PM growth 5Y-26.08%
GM growth 3Y0.23%
GM growth 5Y0.13%
NXP Yearly Profit, Operating, Gross MarginsNXP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

More info and screens

5

2. Health

2.1 Basic Checks

NXP has more shares outstanding than it did 5 years ago.
NXP Yearly Shares OutstandingNXP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M 40M 50M
NXP Yearly Total Debt VS Total AssetsNXP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2025 200M 400M 600M

2.2 Solvency

NXP has an Altman-Z score of 52.67. This indicates that NXP is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for NXP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 52.67
ROIC/WACCN/A
WACCN/A
NXP Yearly LT Debt VS Equity VS FCFNXP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2025 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.14 indicates that NXP should not have too much problems paying its short term obligations.
NXP has a Quick Ratio of 1.14. This is a normal value and indicates that NXP is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
NXP Yearly Current Assets VS Current LiabilitesNXP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2025 2M 4M 6M 8M 10M

More info and screens

4

3. Growth

3.1 Past

NXP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 196.15%, which is quite impressive.
Measured over the past years, NXP shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -25.17% on average per year.
The Revenue has been growing slightly by 5.60% in the past year.
Measured over the past years, NXP shows a very strong growth in Revenue. The Revenue has been growing by 26.34% on average per year.
EPS 1Y (TTM)196.15%
EPS 3YN/A
EPS 5Y-25.17%
EPS Q2Q%182%
Revenue 1Y (TTM)5.6%
Revenue growth 3Y30.04%
Revenue growth 5Y26.34%
Sales Q2Q%7.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NXP Yearly Revenue VS EstimatesNXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.38, the valuation of NXP can be described as very reasonable.
When comparing the Price/Earnings ratio of NXP to the average of the S&P500 Index (27.32), we can say NXP is valued rather cheaply.
Industry RankSector Rank
PE 9.38
Fwd PE N/A
NXP Price Earnings VS Forward Price EarningsNXP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXP Per share dataNXP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

NXP has a Yearly Dividend Yield of 3.97%.
NXP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 3.97%

5.2 History

NXP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
NXP Yearly Dividends per shareNXP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NXP Yearly Income VS Free CF VS DividendNXP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M

More info and screens

NUVEEN SELECT TAX-FREE INC

NYSE:NXP (9/26/2025, 8:17:42 PM)

14.45

-0.14 (-0.96%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)12-01 2025-12-01
Inst Owners16.44%
Inst Owner Change0.23%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap734.78M
Analysts45
Price TargetN/A
Short Float %0.14%
Short Ratio0.59
Dividend
Industry RankSector Rank
Dividend Yield 3.97%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date09-15 2025-09-15 (0.0535)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.38
Fwd PE N/A
P/S 23.7
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB 1.01
EV/EBITDA N/A
EPS(TTM)1.54
EY10.66%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.61
BVpS14.27
TBVpS14.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.22%
ROE 10.33%
ROCE 4.13%
ROIC 3.27%
ROICexc 3.27%
ROICexgc 3.27%
OM 96.77%
PM (TTM) 241.94%
GM 95.35%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y27.76%
ROICexcg growth 5Y2.47%
ROICexc growth 3Y27.77%
ROICexc growth 5Y2.48%
OM growth 3Y0.23%
OM growth 5Y0.16%
PM growth 3YN/A
PM growth 5Y-26.08%
GM growth 3Y0.23%
GM growth 5Y0.13%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z 52.67
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)196.15%
EPS 3YN/A
EPS 5Y-25.17%
EPS Q2Q%182%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.6%
Revenue growth 3Y30.04%
Revenue growth 5Y26.34%
Sales Q2Q%7.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.14%
EBIT growth 3Y30.35%
EBIT growth 5Y26.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A